Skip to main content
EVGN
NASDAQ Industrial Applications And Services

Evogene Upsizes ATM to $3.3M, Reveals $1.75M Already Sold Amid Proxy Fight

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.621
Mkt Cap
$7.613M
52W Low
$0.37
52W High
$1.5
52W Position info
68% above low
Off High info
59% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

EVGN sits 68% above its 52-week low of $0.37.

Summary

Evogene upsized its ATM offering to $3.3 million and revealed $1.75 million in shares already sold, adding dilution pressure amid an activist proxy battle and Nasdaq delisting risk.


Key Events · Financing and Capital Events · EVGN

  • ATM Upsized to $3.3M

    The maximum aggregate offering price under the ATM program was increased from $2.93 million to $3.29 million, an upsize of $361,613.

  • $1.75M Already Sold

    Evogene disclosed that $1,753,025.13 of ordinary shares have already been sold under the Sales Agreement to date, representing over half of the original $2.93 million capacity.

  • Dilution at Depressed Prices

    With the stock trading at $0.58, the ATM sales are highly dilutive; the $1.75 million sold so far equates to roughly 3 million shares, or about 23% of the public float.

  • Proxy Fight Backdrop

    The ATM upsize and sales come just days after an activist group acquired a 16.7% stake and demanded a special meeting to replace most of the board, adding governance uncertainty.


Analysis · EVGN · Industrial Applications And Services

Evogene increased its at-the-market offering capacity by $361,613 to $3.3 million and disclosed that $1.75 million in shares have already been sold under the program. The upsize and actual sales come as the company faces an activist proxy fight and delisting concerns, making the dilution more acute for existing shareholders. The ATM provides critical liquidity but at the cost of significant dilution at depressed prices.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EVGN was trading at $0.62 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $7.6M. The 52-week trading range was $0.37 to $1.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EVGN - Latest Insights

EVGN
Nov 19, 2026, 7:12 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $0.3233
Real-time Price: $0.313 info
Change: -$0.0103 (-3%) info
Market Cap: $5.708M info
EVGN
Nov 16, 2026, 7:01 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3646
Real-time Price: $0.313 info
Change: -$0.0516 (-14%) info
Market Cap: $5.708M info
EVGN
Oct 06, 2026, 4:00 PM EDT
Source: PR Newswire
Importance Score:
9
Price at Filing: $0.4101
Real-time Price: $0.313 info
Change: -$0.0971 (-24%) info
Market Cap: $5.708M info
EVGN
Sep 30, 2026, 7:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $0.4168
Real-time Price: $0.313 info
Change: -$0.1038 (-25%) info
Market Cap: $5.708M info
EVGN
Sep 28, 2026, 4:10 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $0.3907
Real-time Price: $0.313 info
Change: -$0.0777 (-20%) info
Market Cap: $5.708M info